VEGFA and cancer: Arginine grafted bio-reducible ABP was incorporated to PAMAM dendrimers to deliver anti-vascular endothelial growth factor (VEGF)-siRNA to cancer cell lines such as human hepatocarcinoma (Huh-7), human lung adenocarcinoma (A549), and human fibrosarcoma (HT1080) cells.